Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma

Journal of Steroid Biochemistry and Molecular Biology

Volumn 104, Issue 3-5, 2007, Pages 93-99

  Sánchez Archidona, Ana R ^a   Jiménez, María A ^a   Pérez Alenza, Dolores ^a   Silván, Gema ^a   Illera, Juan C ^a   Peña, Laura ^a   Dunner, Susana ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Canine inflammatory mammary carcinoma; Oestrone sulphate pathway; Steroid hormones; Steroid receptors

Indexed keywords

ANDROGEN RECEPTOR; AROMATASE; ESTROGEN RECEPTOR; ESTROGEN SULFOTRANSFERASE; ESTRONE SULFATE; FAT DROPLET; MESSENGER RNA; STEROID; STERYL SULFATASE;

ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANINE INFLAMMATORY MAMMARY CARCINOMA; CONTROLLED STUDY; DOG; FEMALE; HORMONE SYNTHESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID BLOOD LEVEL; STEROIDOGENESIS; TISSUE LEVEL;

ANIMALS; CARCINOMA; DOGS; ESTRONE; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MASTITIS; SIGNAL TRANSDUCTION; STEROIDS; STERYL-SULFATASE;

EID: 34250005715     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.03.014     Document Type: Article

References (42)

1. Levine P.H., Steinhorn S.C., Ries L.G., and Aron J.L. Inflammatory breast cancer. The experience of the surveillance, epidemiology, and end results (SEER) program. J. Natl. Cancer Inst. 74 (1985) 291-297
2. Somlo G., Doroshow J.H., Forman S.J., Odom-Mayon T., Lee J., Chow W., Hamasaki V., Leong Jr. L., Morgan R., Margolin K., Raschko J., Shibata S., Telef M., Yen Y., Simpson J., and Molina A. High-dose chemotherapy and stem cell rescue in the treatment of high risk breast cancer: prognostic indicators of progression-free and overall survival. J. Clin. Oncol. 15 (1997) 2882-2893
3. Victor S.J., Horwitz E.M., Kini V.R., Martinez A.A., Pettinga J.E., Dmuchowski C.F., Decker D.A., Wilner F.M., and Vicini F.A. Impact of clinical, pathologic, and treatment-related factors of patients with local advanced breast cancer treated with multimodality therapy. Am. J. Clin. Oncol. 22 (1999) 119-125
4. van Golen K.J., Davies S., Wu Z.F., Wang Y., Bucana C.D., Root H., Chandrasekharappa S., Strawderman M., Ethier S.P., and Merajver S.D. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPasa correlate with the inflammatory breast cancer phenotype. Clin. Cancer Res. 5 9 (2000) 5832-5838
5. Peña L., Pérez-Alenza M.D., Rodríguez-Bertos A., and Nieto A. Canine inflammatory mammary carcinoma: histopathology, inmunohistochemistry, and clinical implications of 21 cases. Breast Cancer Res. Treat. 78 (2003) 141-148
6. Alpaugh M.L., Tomlinson J.S., Shao Z.M., and Barsky S.H. A novel human xenograft model of inflammatory breast cancer. Cancer Res. 59 20 (1999) 5079-5084
7. Pérez-Alenza M.D., Tabanera E., and Peña L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J. Am. Vet. Med. Assoc. 219 (2001) 110-1114
8. Tavassoli F.A. Inflammatory carcinoma. Infiltrating carcinoma: special types. Pathology of the Breast. 2nd ed. (1999), McGraw-Hill, New York pp. 519-522, 538-541
9. Giordano S.H. Update on locally advanced breast cancer. Oncologist 8 (2003) 521-530
10. Jaiyesimi I.A., Buzdar A.U., and Hortobagyi G. Inflammatory breast cancer: a review. J. Clin. Onol. 10 (1992) 1014-1024
11. Vermeulen A., Deslypere J.P., and Paridaens R. Steroid dynamics in the normal and carcinomaotus mammary gland. J. Steroid Biochem. 25 (1986) 799-802
12. Blankenstein M.A., van de Ven J., Maitimu-Smeele I., Donker G.H., de Jong P.C., Daroszewski J., Szymczak J., Milewicz A., and Thijseen J.H. Intratumoral levels of estrogens in breast cancer. J. Steroid Biochem. Mol. Biol. 69 (1999) 293-297
13. Abul-Hajj Y.J., Iverson R., and Kiang D.T. Aromatization of androgens by human breast cancer. Steroids 33 (1979) 205-222
14. Lipton A., Santner S.J., Santen R.J., Harvey H.A., Feil P.D., White-Hershey D., Bartholomew M.J., and Antle C.E. Aromatase activity in primary and metastatic human breast cancer. Cancer 59 (1987) 779-782
15. Dao T.L., Hayes C., and Libby C.P.R. Steroid sulfatase activities in human breast tumors. Proc. Soc. Exp. Biol. Med. 146 (1984) 381-384
16. Pasqualini J.R., Gelly C., and Lecerf F. Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 8 (1986) 233-240
17. Pasqualini J.R., Gelly C., Nguyen B.L., and Vella C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 34 (1989) 155-163
18. Edery M., Goussard J., Dehennin L., Scholler R., Reiffsteck J., and Drosdowsky M.A. Endogenous oestradiol-17b concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur. J. Cancer 17 (1981) 115-120
19. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., and Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 81 4 (1996) 1460-1464
20. J.C. Illera, M.D. Pérez-Alenza, A. Nieto, M.A. Jiménez, G. Silván, S. Dunner, L. Peña, Steroids and receptors in canine mammary cancer, Steroids, April 20, 2006.
21. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 245 (1997) 154-160
22. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 7 (2002) (research0034)
23. Chambler A.F., Drew P.J., Hill D.A., Darzi A., and Monson J.R. Inflammatory breast carcinoma. Surg. Oncol. 4 (1995) 245-254
24. Susaneck S.J., Allen T.A., Hoopes J., Withrow S.J., and Macy D.W. Inflammatory mammary carcinoma in the dog. J. Am. An. Hosp. Assoc. 19 (1983) 971-976
25. Chang S., Parker S.L., Pham T., Buzdar A., and Hursting S.D. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology and end result program of the National Cancer Institute, 1975-1992. Cancer 75 Suppl. 1 (1994) 275-282
26. Illera J.C., Sliván G., Pérez-Alenza M.D., Sánchez-Archidona A.R., Nieto A., and Peña L. The possible role of IGF-I and androgens in the development of canine inflammatory mammary carcinoma. Proceedings of the Fourth Hormonal Carcinogenesis (2003)
27. Liao D.J., and Dickson R.B. Roles of androgens in the development, growth and carcinogenesis of the mammary gland. J. Steriod Biochem. Mol. Biol. 80 (2002) 175-189
28. Maggiolini M., Donze O., Jeannin E., Andò S., and Picard D. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor α. Cancer Res. 59 (1999) 4864-4869
29. Peña L., Silván G., Pérez-Alenza M.D., Nieto A., and Illera J.C. Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. J. Steroid Biochem. Mol. Biol. 84 (2003) 211-216
30. Zhou J., NG S., Adesanya-Famuiya O., Anderson K., and Boundy C.A. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J. 14 12 (2000) 1725-1730
31. Langer M., Kubista E., Schemper M., and Spona J. Androgen receptors, serum androgen levels and survival of breast cancer patients. Arch. Gynecol. Obstet. 247 (1999) 203-209
32. Kuenen-Boumeester V., Van der Kwast T.H., van Putten W.L., Claassen C., van Ooijen B., and Henzen-Logmans S.C. Inmunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int. J. Cancer 52 (1992) 581-584
33. Murphy L.C., and Watson P.H. Is oestrogen receptor-β a predictor of endocrine therapy responsiveness in human breast cancer?. Endocr. Relat. Cancer 13 (2006) 327-334
34. Girdler F., and Brotherick I. The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: a review. Breast 9 (2000) 194-200
35. Thijssen J.J.H., Blankenstein M.A., Miller W.R., and Milewicz A. Estrogen in tissues: uptake from the peripheral circulation or local production. Steroids 50 (1987) 1-3
36. Chetrite G.S., Cortes-Prieto J., Philippe J.C., and Pasqualini J.R. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J. Steroid Biochem. Mol. Biol. 72 1-2 (2000) 23-27
37. Reed M.J., and Puroih A. Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev. Endocr. Relat. Cancer 45 (1993) 51-62
38. Horbkirk R. Steroid sulfation. Trends Endocr. Metab. 4 (1993) 69-74
39. Utsumi T., Yoshimura N., Takeuchi S., Ando J., Maruta M., Maeda K., and Harada N. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Res. 59 (1999) 377-381
40. Noel C.T., Reed M.J., Jacobs H.S., and James V.H. The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J. Steroid Biochem. 14 11 (1981) 1101-1105
41. Ruder H.J., Loriaux L., and Lipsett M.B. Estrone sulfate: production rate and metabolism in man. J. Clin. Invest. 51 4 (1972) 1020-1033
42. Dabrosin C., Margetts P.J., and Gauldie J. Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. Int. J. Cancer 107 (2003) 535-540